We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Generic Line interviewed Bruce Downey, chairman and CEO of Barr Pharmaceuticals, a specialty company engaged in the development, manufacture and marketing of proprietary and generic prescription pharmaceuticals.